Consequently, HSP47 is receiving significant attention as a multifunctional regulator of both ECM accumulation and EMT during the dysregulated remodeling process in the upper airway, which may be considered as a meaningful therapeutic target for refractory CRS patients. This evidence concerns the gene SERPINH1 and congenital rubella syndrome.